Probio-40

by Nutracraft · capsule · 60 capsules

  • On the market (NIH)
  • UPC X000IH56RX
  • DSLD label 246545
  • Serving 1 capsule; amounts per 2 capsules
  • 30 servings

Probio-40 by Nutracraft lists 6 ingredients; 6 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on April 22, 2021.

What is in Probio-40?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Probio-40: Supplement Facts rows against the market (DSLD label 246545, January 2026 release)
IngredientAmount% DVAmong products listing it
Proprietary Blend of Probiotic BacteriaProprietary Blend of Probiotic Bacteria Note: (Maktrek (Bi-Pass Technology)) (40 billion organisms)
Lactobacillus acidophilus (La-14)in the blend, no amount given
Bifidobacterium lactis (Bl-04)in the blend, no amount given
Lactobacillus plantarum Lp-115in the blend, no amount given
Lactobacillus paracasei Lpc-37in the blend, no amount given
Marine PolysaccharidesMarine Polysaccharide Complexin the blend, no amount given
Fructooligosaccharidein the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 246545 (entered April 22, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 6 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use As a dietary supplement take two (2) capsules once daily. For best results, taken one (1) capsule during the day and one (1) capsule in the evening. Repeat the process daily. Do not exceed two (2) capsules per day.
Warnings
Keep out of the reach of children.
Do not use if safety seal is damaged or missing.
Storage
Keep refrigerated to maintain potency
Store in a cool, dry place.

Source: label statements in DSLD label 246545.

What else is on the label?

Other ingredients: Cellulose, Rice Dextrin, L-Leucine.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): GMP Good Manufacturing Practice Made in USA.

How many labels does Probio-40 have?

One label is on file, entered on April 22, 2021.

  1. Label 246545 (current) Entered April 22, 2021 · on the market · 60 capsules · UPC X000IH56RX

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Nutracraft.com (distributor), Beaverton, OR. All Nutracraft products.

Where next?